{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:43:02Z","timestamp":1790779382881,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jpba.2014.02.021","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T12:17:17Z","timestamp":1394453837000},"page":"130-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase"],"prefix":"10.1016","volume":"95","author":[{"given":"Ann-Kathrin","family":"Schoenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Vierfu\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"L\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Alban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2014.02.021_bib0005","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1160\/TH09-02-0091","article-title":"Heparin, heparan sulfate and heparanase in inflammatory reactions","volume":"102","author":"Li","year":"2009","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.jpba.2014.02.021_bib0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12307-011-0082-7","article-title":"Significance of heparanase in cancer and inflammation","volume":"5","author":"Vlodavsky","year":"2012","journal-title":"Cancer Microenvironment"},{"key":"10.1016\/j.jpba.2014.02.021_bib0015","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1182\/blood.V70.2.551.551","article-title":"Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species","volume":"70","author":"Bar-Ner","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2014.02.021_bib0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.2910400414","article-title":"Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases","volume":"40","author":"Parish","year":"1987","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.jpba.2014.02.021_bib0025","doi-asserted-by":"crossref","first-page":"9661","DOI":"10.1016\/S0021-9258(18)92871-1","article-title":"Suramin. A potent inhibitor of melanoma heparanase and invasion","volume":"266","author":"Nakajima","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jpba.2014.02.021_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0707182","article-title":"Heparanase: a target for drug discovery in cancer and inflammation","volume":"151","author":"McKenzie","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.jpba.2014.02.021_bib0035","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/1389557043403729","article-title":"The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation","volume":"4","author":"Ferro","year":"2004","journal-title":"Mini-Reviews in Medicinal Chemistry"},{"key":"10.1016\/j.jpba.2014.02.021_bib0040","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.2174\/092986706777935230","article-title":"Development of heparanase inhibitors for anti-cancer therapy","volume":"13","author":"Miao","year":"2006","journal-title":"Current Medical Chemistry"},{"key":"10.1016\/j.jpba.2014.02.021_bib0045","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2174\/138161207781039742","article-title":"Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate","volume":"13","author":"Vlodavsky","year":"2007","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.jpba.2014.02.021_bib0050","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.bmc.2013.01.033","article-title":"Hit identification of novel heparanase inhibitors by structure- and ligand-based approaches","volume":"21","author":"Gozalbes","year":"2013","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.jpba.2014.02.021_bib0055","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.bmcl.2005.03.014","article-title":"Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor","volume":"15","author":"Courtney","year":"2005","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.jpba.2014.02.021_bib0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0008-6215(01)00300-7","article-title":"Determination of the composition of the oligosaccharide phosphate fraction of Pichia (Hansenula) holstii NRRL Y-2448 phosphomannan by capillary electrophoresis and HPLC","volume":"337","author":"Ferro","year":"2002","journal-title":"Carbohydrate Research"},{"key":"10.1016\/j.jpba.2014.02.021_bib0065","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1021\/jm201708h","article-title":"Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis","volume":"55","author":"Ferro","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.jpba.2014.02.021_bib0070","doi-asserted-by":"crossref","first-page":"12103","DOI":"10.1074\/jbc.M414217200","article-title":"Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting","volume":"280","author":"Naggi","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jpba.2014.02.021_bib0075","doi-asserted-by":"crossref","first-page":"e21106","DOI":"10.1371\/journal.pone.0021106","article-title":"M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jpba.2014.02.021_bib0080","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.fob.2013.07.007","article-title":"Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues","volume":"3","author":"Hammond","year":"2013","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.jpba.2014.02.021_bib0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ab.2012.04.032","article-title":"Development of both colorimetric and fluorescence heparinase activity assays using fondaparinux as substrate","volume":"427","author":"Schiemann","year":"2012","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.jpba.2014.02.021_bib0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ab.2009.09.007","article-title":"Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening","volume":"396","author":"Hammond","year":"2010","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.jpba.2014.02.021_bib0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1055\/s-2007-982079","article-title":"High-performance liquid chromatographic\/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase","volume":"33","author":"Bisio","year":"2007","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1016\/j.jpba.2014.02.021_bib0100","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1021\/bi00462a026","article-title":"Examination of the substrate specificity of heparin and heparan sulfate lyases","volume":"29","author":"Linhardt","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.jpba.2014.02.021_bib0105","doi-asserted-by":"crossref","first-page":"10365","DOI":"10.1073\/pnas.97.19.10365","article-title":"Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin","volume":"97","author":"Shriver","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jpba.2014.02.021_bib0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/glycob\/4.3.289","article-title":"Action pattern of polysaccharide lyases on glycosaminoglycans","volume":"4","author":"Jandik","year":"1994","journal-title":"Glycobiology"},{"key":"10.1016\/j.jpba.2014.02.021_bib0115","doi-asserted-by":"crossref","first-page":"14504","DOI":"10.1074\/jbc.M110.104166","article-title":"Unraveling the specificity of heparanase utilizing synthetic substrates","volume":"285","author":"Peterson","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jpba.2014.02.021_bib0120","unstructured":"J.C. Yvin, S. Alban, G. Franz, Anti-inflammatory and healing medicine based on laminarin sulphate, PCT Int Appl Patent No. WO 2002036132 (2002)."},{"key":"10.1016\/j.jpba.2014.02.021_bib0125","article-title":"A concert of actions contributes to the antimetastastic activity of the semisynthetic glucan sulfate PS3","volume":"1","author":"Alban","year":"2005","journal-title":"Haematologica Reports"},{"key":"10.1016\/j.jpba.2014.02.021_bib0130","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/jid.2008.358","article-title":"PS3, a semisynthetic beta-1,3-glucan sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functions","volume":"129","author":"Alban","year":"2009","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.jpba.2014.02.021_bib0135","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/glycob\/cwn151","article-title":"Pharmacological profiles of animal- and nonanimal-derived sulfated polysaccharides\u2014comparison of unfractionated heparin, the semisynthetic glucan sulfate PS3, and the sulfated polysaccharide fraction isolated from Delesseria sanguinea","volume":"19","author":"Groth","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.jpba.2014.02.021_bib0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-2007-1001898","article-title":"Gas\u2013liquid chromatography\u2013mass spectrometry analysis of anticoagulant active curdlan sulfates","volume":"20","author":"Alban","year":"1994","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1016\/j.jpba.2014.02.021_bib0145","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1021\/bm010032u","article-title":"Partial synthetic glucan sulfates as potential new antithrombotics: a review","volume":"2","author":"Alban","year":"2001","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jpba.2014.02.021_bib0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0008-6215(97)10060-X","article-title":"Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation","volume":"306","author":"Maruyama","year":"1998","journal-title":"Carbohydrate Research"},{"key":"10.1016\/j.jpba.2014.02.021_bib0155","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00216-010-3867-5","article-title":"Simple fluorescence assay for quantification of OSCS in heparin","volume":"399","author":"L\u00fchn","year":"2011","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/j.jpba.2014.02.021_bib0160","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1021\/bm900501g","article-title":"Optimized and standardized isolation and structural characterization of anti-inflammatory sulfated polysaccharides from the red alga Delesseria sanguinea (Hudson) Lamouroux (Ceramiales, Delesseriaceae)","volume":"10","author":"Gr\u00fcnewald","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jpba.2014.02.021_bib0165","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1529-8817.2006.00204.x","article-title":"A multi-gene molecular investigation of the kelp (Laminariales, Phaeophyceae) supports substantial taxonomic re-organization","volume":"42","author":"Lane","year":"2006","journal-title":"Journal of Phycology"},{"key":"10.1016\/j.jpba.2014.02.021_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpba.2009.12.014","article-title":"Development and evaluation of a fluorescence microplate assay for quantification of heparins and other sulfated carbohydrates","volume":"52","author":"L\u00fchn","year":"2010","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.jpba.2014.02.021_bib0175","doi-asserted-by":"crossref","first-page":"7701","DOI":"10.1002\/chem.200700677","article-title":"A fluorescent polymeric heparin sensor","volume":"13","author":"Sun","year":"2007","journal-title":"Chemistry"},{"key":"10.1016\/j.jpba.2014.02.021_bib0180","first-page":"290","article-title":"Inhibition of tumor metastasis by heparanase inhibiting species of heparin","volume":"14","author":"Vlodavsky","year":"1994","journal-title":"Invasion and Metastasis"},{"key":"10.1016\/j.jpba.2014.02.021_bib0185","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bcp.2006.05.006","article-title":"The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity","volume":"72","author":"Fritzsche","year":"2006","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.jpba.2014.02.021_bib0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000175157","article-title":"Non-anticoagulant heparins and inhibition of cancer","volume":"36","author":"Casu","year":"2008","journal-title":"Pathophysiology of Haemostasis and Thrombosis"},{"key":"10.1016\/j.jpba.2014.02.021_bib0195","first-page":"3433","article-title":"Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity","volume":"59","author":"Parish","year":"1999","journal-title":"Cancer Research"},{"key":"10.1016\/j.jpba.2014.02.021_bib0200","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1055\/s-2007-982087","article-title":"O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasis","volume":"33","author":"Borgenstrom","year":"2007","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1016\/j.jpba.2014.02.021_bib0205","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nbt1407","article-title":"Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events","volume":"26","author":"Guerrini","year":"2008","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.jpba.2014.02.021_bib0210","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1055\/s-2008-1074549","article-title":"Elastase inhibition assay with peptide substrates \u2013 an example for the limited comparability of in vitro results","volume":"74","author":"Groth","year":"2008","journal-title":"Planta Medica"},{"key":"10.1016\/j.jpba.2014.02.021_bib0215","series-title":"Neuartige antiphlogistisch wirksame \u03b2-1,3-Glucansulfate: Partialsynthese und physiologische Testung, Chemie und Pharmazie","first-page":"198","author":"Stibich","year":"2001"},{"key":"10.1016\/j.jpba.2014.02.021_bib0220","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1021\/bm8014158","article-title":"Evaluation of seasonal variations of the structure and anti-inflammatory activity of sulfated polysaccharides extracted from the red alga Delesseria sanguinea (Hudson) Lamouroux (Ceramiales, Delesseriaceae)","volume":"10","author":"Gr\u00fcnewald","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jpba.2014.02.021_bib0225","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.carres.2010.07.009","article-title":"Further studies on the composition and structure of a fucoidan preparation from the brown alga Saccharina latissima","volume":"345","author":"Bilan","year":"2010","journal-title":"Carbohydrate Research"},{"key":"10.1016\/j.jpba.2014.02.021_bib0230","doi-asserted-by":"crossref","first-page":"e17283","DOI":"10.1371\/journal.pone.0017283","article-title":"Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from Laminaria saccharina brown seaweed","volume":"6","author":"Croci","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jpba.2014.02.021_bib0235","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.3390\/md9102106","article-title":"Important determinants for fucoidan bioactivity: a critical review of structure\u2013function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds","volume":"9","author":"Ale","year":"2011","journal-title":"Marine Drugs"},{"key":"10.1016\/j.jpba.2014.02.021_bib0240","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/md9101731","article-title":"Therapies from fucoidan: multifunctional marine polymers","volume":"9","author":"Fitton","year":"2011","journal-title":"Marine Drugs"},{"key":"10.1016\/j.jpba.2014.02.021_bib0245","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00253-011-3666-8","article-title":"Algal fucoidan: structural and size-dependent bioactivities and their perspectives","volume":"93","author":"Morya","year":"2012","journal-title":"Applied Microbiology and Biotechnology"},{"key":"10.1016\/j.jpba.2014.02.021_bib0250","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.lfs.2006.05.020","article-title":"Colorimetric heparinase assay for alternative antimetastatic activity","volume":"79","author":"Ahn","year":"2006","journal-title":"Life Sciences"},{"key":"10.1016\/j.jpba.2014.02.021_bib0255","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7164\/antibiotics.53.211","article-title":"CRM646-A and -B, novel fungal metabolites that inhibit heparinase","volume":"53","author":"Ko","year":"2000","journal-title":"Journal of Antibiotics (Tokyo)"},{"key":"10.1016\/j.jpba.2014.02.021_bib0260","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1242\/jcs.108.11.3591","article-title":"Characterisation of a laminarin sulphate which inhibits basic fibroblast growth factor binding and endothelial cell proliferation","volume":"108","author":"Hoffman","year":"1995","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.jpba.2014.02.021_bib0265","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1593\/neo.101734","article-title":"Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase","volume":"13","author":"Borsig","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.jpba.2014.02.021_bib0270","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1096\/fj.07-8450com","article-title":"P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins","volume":"21","author":"Hostettler","year":"2007","journal-title":"FASEB Journal"},{"key":"10.1016\/j.jpba.2014.02.021_bib0275","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1538-7836.2007.02497.x","article-title":"Cancer and thrombosis: from molecular mechanisms to clinical presentations","volume":"5","author":"B\u00fcller","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708514001125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708514001125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T15:25:03Z","timestamp":1648567503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708514001125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":55,"alternative-id":["S0731708514001125"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2014.02.021","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2014.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}